SVB Leerink Maintains Outperform on scPharmaceuticals, Raises Price Target to $12

SVB Leerink analyst Roanna Ruiz maintains scPharmaceuticals (NASDAQ:SCPH) with a Outperform and raises the price target from $11 to $12.

SVB Leerink analyst Roanna Ruiz maintains scPharmaceuticals (NASDAQ:SCPH) with a Outperform and raises the price target from $11 to $12.

Total
0
Shares
Related Posts